Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Fexofenadine Hydrochloride Tablets

Approval Number

国药准字H20090333

Company黑龙江乌苏里江制药有限公司哈尔滨分公司

Registration Date

May 5, 2024

Drug Information

Generic Name

盐酸非索非那定片

Dosage Form

片剂

Strength

60mg

Drug Type

化学药品

Registration Date

May 5, 2024

Company Information

Applicant Company

Company Name黑龙江乌苏里江制药有限公司哈尔滨分公司

Company Address

哈尔滨开发区哈平路集中区渤海路39号

Manufacturing Company

Company Name黑龙江乌苏里江制药有限公司哈尔滨分公司

Company Address

哈尔滨开发区哈平路集中区渤海路39号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸非索非那定片 - NMPA 批准文号 | MedPath